
    
      Patients between the ages of 19-65 who applied to Gaziantep University Faculty of Medicine,
      Department of Gastroenterology and diagnosed with Irritable Bowel Syndrome by the physician
      according to the Rome IV criteria will be included in the study. The aim of the study will be
      explained to the patients and the dietary treatment that will be recommended if they
      participate in the study will be told that they should be followed for 4 weeks. In addition,
      it will be notified that surveys will be conducted at the beginning and end of the 4-week
      period. Written consent will be obtained from individuals who agree to participate in the
      study.

      The minimum number of individuals in each group was determined to be 13 when the power was
      calculated as 80 at a 95% confidence interval. Individuals who accepted to participate in the
      study will be randomized into 4 different groups by minimization method according to age,
      gender, irritable bowel syndrome subtypes (diarrhea, constipation, mixed / undefined) and
      initial irritable bowel syndrome severity scores (mild, moderate, severe):. 1st Group:
      Traditional diet recommendations, 2nd Group: Low FODMAP diet, 3rd Group: Gluten-free diet,
      4th Group: Low-FODMAP gluten-free diet. When individuals are first enrolled in the study,
      they will be trained by the dietician for one hour before the medical nutrition treatment
      they will apply for 4 weeks.

      "Irritable Bowel Syndrome Severity Scoring Scale", "Bristol Stool Scale", "Irritable Bowel
      Syndrome Quality of Life Scale", "Food Consumption Frequency Survey including FODMAP Intake"
      and "Food Consumption Frequency Survey Including Gluten Intake" will be applied to
      individuals at the beginning of the study and at the end of the 4th week.
    
  